ACE and cancer: There is some evidence that long-term use of anti-hypertensives that reduce the activity of the RAS, such as ACE inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), reduces the risk of some cancers, particularly female-specific cancers [10].